NEOGEN CLO Acquires Shares via RSU Vesting, Sells to Cover Taxes
NEOGEN CORP
Subscribe to track NEOG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
NEOGEN CLO Vests RSUs, Acquires Stock
Company: NEOGEN CORP (NEOG) Form: 4 | Filed: 2025-10-09 Significance: Low
Insider: Rocklin Amy M Title: Chief Legal Officer | Relationship: Officer
Transaction (Vesting): • Type: RSU Vesting (Exercise) • Shares Acquired: 9,036 • Price: $5.36 • Value: $48,432.96
Transaction (Tax Withholding): • Type: Sell-to-Cover • Shares Disposed: 3,534 • Price: $5.63 • Value: $19,896.42
Net Result: • Net Shares Acquired: 5,502 • Owned After: 49,672 shares
Key Insight: This is a routine vesting of previously granted equity awards. The sale of shares (Code 'F') was to cover tax liabilities and is not a discretionary market sale, indicating neutral sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: NEOGEN CORP (NEOG)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Legal Officer of NEOGEN CORP acquired 9,036 shares through the vesting of Restricted Stock Units (RSUs) and simultaneously disposed of 3,534 shares to cover the associated tax liability. This is a non-discretionary event related to executive compensation and does not represent an open-market investment decision.
- Market Impact: Neutral. Transactions coded 'M' (Exercise) and 'F' (Tax Withholding) are common and typically do not influence market sentiment as they are not indicative of an insider's forward-looking view on the company's performance.
Company Information
| Field | Value |
|---|---|
| Company | NEOGEN CORP |
| Ticker Symbol | NEOG |
| CIK | 0000711377 |
| Industry | In Vitro & In Vivo Diagnostic Substances |
Insider Information
| Field | Value |
|---|---|
| Name | Rocklin Amy M |
| CIK | 0001959089 |
| Title/Position | Chief Legal Officer |
| Relationship | Officer |
Transaction Details
This filing reports two key non-derivative transactions following the exercise of a derivative security (RSUs).
Transaction 1: Acquisition via Exercise
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | M - Exercise of derivative security |
| Security Type | Common Stock |
| Shares Involved | 9,036 |
| Price Per Share | $5.36 |
| Total Value | $48,432.96 |
| Ownership Type | Direct |
Transaction 2: Disposition for Taxes
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-07 |
| Transaction Code | F - Payment of tax liability by withholding security |
| Security Type | Common Stock |
| Shares Involved | 3,534 |
| Price Per Share | $5.63 |
| Total Value | $19,896.42 |
| Ownership Type | Direct |
Net Position Change
| Field | Value |
|---|---|
| Net Shares Acquired | 5,502 |
| Shares Owned After | 49,672 |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The acquisition of shares resulted from the vesting of a pre-existing compensation award, not a new investment decision. The corresponding disposition was an automatic 'sell-to-cover' transaction to satisfy tax obligations. The market generally views such transactions as neutral events.
Volume & Sentiment
- Expected Volume Impact: Minimal. The shares sold to cover taxes contribute to daily volume but are not seen as a significant trading signal.
- Sentiment Indicator: Neutral. This filing does not provide a bullish or bearish signal as the transactions are part of a standard executive compensation plan.
Investment Insights
Positive Market Indicators
- The vesting increases the insider's direct ownership in the company, aligning their interests more closely with shareholders, albeit through a planned compensation mechanism.
Risk Factors
- No direct risk factors are apparent from this filing. It is a routine administrative transaction.
Key Takeaways
- Non-Discretionary Event: The core of this filing is the vesting of RSUs, a scheduled part of the insider's compensation package.
- Tax-Related Sale: The sale of 3,534 shares (Code 'F') is not a reflection of negative sentiment but a common method to handle the tax burden from vested equity.
- Low Signaling Value: Unlike open-market purchases or sales, this combination of transactions offers little to no insight into the insider's perspective on the company's future prospects.
Contextual Analysis
Timing Significance
- The transaction occurred on a specific vesting date outlined in the original RSU grant. The timing is dictated by the compensation agreement, not by market conditions.
Transaction Context
- The filing includes a derivative transaction showing the disposition of 9,036 RSUs (Code 'M') which were converted into an equal number of common stock shares. The remark clarifies: "On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock."
Company Context
- Analysis of this filing should be paired with an understanding of NEOGEN's recent performance, earnings reports, and any major corporate announcements to place the executive's total holdings into a broader perspective.
Risk Assessment
Risk Level: Low
Risk Factors
- This filing itself presents no material risks to investors.
Market Considerations
- Investors should differentiate between these automated, compensation-related transactions and discretionary open-market trades when assessing insider sentiment.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-09 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
